Schizophrenia News and Research

Latest Schizophrenia News and Research

CMHA calls to extend Employment Insurance benefits and Pharmacare program for mentally-ill patients

CMHA calls to extend Employment Insurance benefits and Pharmacare program for mentally-ill patients

ACNP 2009 to feature research on PTSD, biomarkers for schizophrenia and treatment for gambling addiction

ACNP 2009 to feature research on PTSD, biomarkers for schizophrenia and treatment for gambling addiction

NYSE Amex to delist Cortex Pharmaceuticals

NYSE Amex to delist Cortex Pharmaceuticals

Successful reduction in the levels of aggregated Abeta with GSMs

Successful reduction in the levels of aggregated Abeta with GSMs

Psychological trauma leaves a trail of damage in a child's brain, reveal scientists

Psychological trauma leaves a trail of damage in a child's brain, reveal scientists

Two Brown University faculty members receive federal funding for new neuroscience research projects

Two Brown University faculty members receive federal funding for new neuroscience research projects

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

FDA approves once-daily SEROQUEL XR Extended Release Tablets

FDA approves once-daily SEROQUEL XR Extended Release Tablets

Climate change can cause major impact on global mental health

Climate change can cause major impact on global mental health

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Alkermes licenses Medifusion technology to develop TNF receptor-Fc fusion protein

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Generic erosion to decrease branded atypical antipsychotics schizophrenia drug market to $5.2B

Integrated eating disorders center to be launched shortly

Integrated eating disorders center to be launched shortly

Galenea and Otsuka Pharmaceutical extend their research and development collaboration

Galenea and Otsuka Pharmaceutical extend their research and development collaboration

MRI pioneer honored with MRC Millennium Medal

MRI pioneer honored with MRC Millennium Medal

Antipsychotic medications increase the levels of inflammation markers, find researchers

Antipsychotic medications increase the levels of inflammation markers, find researchers

Pharmacy-based intervention improves antipsychotic adherence among patients with mental illnesses

Pharmacy-based intervention improves antipsychotic adherence among patients with mental illnesses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.